Brii Biosciences Ltd

Brii Bio Presents Cross-Study Analysis of Post-Treatment HBsAg Rebound at APASL 2026

Brii Biosciences and OpenBench Announce AI-Driven Collaboration for Proprietary Technology Platform

Brii Biosciences Presents Late-Breaking Data from Ongoing Phase 2 ENSURE Study at AASLD 2025, Reinforcing BRII-179's Potential as a Curative Treatment for Chronic Hepatitis B

Brii Biosciences Announces Publication of Phase 2 ENSURE Study Results in Nature Medicine

Brii Biosciences Provides Corporate Updates and Reports 2025 Interim Financial Results